# University of Liverpool

Organization · id `cardio:org-university-of-liverpool` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 04xs57h96](<https://ror.org/04xs57h96>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 8 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 04xs57h96 by an exact name.

## The registry's words

- Sponsor name: University of Liverpool
- Sponsor class: OTHER
- ROR name: University of Liverpool

## Connected pages

- Sponsors: EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol (`cardio:ct-nct01119261`)
- Sponsors: EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon (`cardio:ct-nct01119274`)
- Sponsors: EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin (`cardio:ct-nct01119300`)
- Sponsors: Clinical Trials for Elderly Patients With Multiple Disease (`cardio:ct-nct01960907`)
- Sponsors: A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients (`cardio:ct-nct02616666`)
- Sponsors: The Efficacy and Safety of Pirfenidone in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction (`cardio:ct-nct02932566`)
- Sponsors: PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation (`cardio:ct-nct03996772`)
- Sponsors: The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy (`cardio:ct-nct04706429`)

## Provenance

Content hash: 6d4d486d10a8215fc58896b4d551667a1f27d891f4bd98ea0dfbf26fe625033e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
